PAR 6.12% 26.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Presentation to Emerging Leaders Conference, page-26

  1. 1,142 Posts.
    lightbulb Created with Sketch. 201
    Slide 25 also mentions possibility of trial extending to Japan.
    I think the pathway to commercialisation might be slightly simpler in Japan.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.